Tenofovir Disoproxil Fumarate Tablet
Product Images NDC 69097-533

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Tenofovir Disoproxil Fumarate (NDC 69097-533). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Cipla Usa Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

6c2c9baa Dd0d 4380 8cdf F6b4d542e079 01

Chemical structure of Tenofovir disoproxil fumarate, an active ingredient in the oral tablet form by Cipla USA Inc. The image depicts the molecular arrangement of atoms including nitrogen, oxygen, carbon, hydrogen, and phosphorus within the compound.*

FDA Label Image

6c2c9baa Dd0d 4380 8cdf F6b4d542e079 02

Label for Tenofovir Disoproxil Fumarate Tablets 300 mg by Cipla USA Inc. The label shows a white background with blue and black text, including the NDC 69097-533-02. It specifies 30 tablets per container, with dosage and storage instructions, and includes manufacturing details for Cipla Ltd., India, and Cipla USA, Inc., New Jersey. A barcode and QR code are present, along with an area designated for batch overprinting (serial number, expiry, lot).*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.